Advertisement

PharmacoEconomics

, Volume 19, Supplement 2, pp 13–19 | Cite as

Using Humanistic Health Outcomes Data in Asthma

  • Elizabeth F. Juniper
Current Opinion

Abstract

One of the aims of treatment of asthma is to improve patient well-being,which incorporates the concept of patients’ perceptions of how they feel and their ability to function in their everyday life [health-related quality of life (HR-QOL)]. The weak association between conventional measures of clinical status in asthma and asthma-specific quality of life means that quality of life must be measured directly — it cannot be inferred from clinical measures. HR-QOL is measured using instruments which elicit information from patients about the impact of the disease and its treatment on both their physical and emotional functioning. Such instruments may be generic (used for all diseases) or specific to a particular group of patients, function or disease. Disease-specific quality-of-life questionnaires are useful in clinical trials and practice because they are more responsive to small but clinically important changes than generic instruments. Generic instruments provide an estimate of the patients’ burden of illness that can be compared with the burden experienced by patients with other medical conditions. Consequently, HR-QOL should be included as an outcome measure in all assessments of asthma.

Keywords

Asthma Minimal Important Difference Generic Instrument Sickness Impact Profile Airway Narrowing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers, 1996: 11–23Google Scholar
  2. 2.
    Guyatt GH, Naylor D, Juniper EF, et al. Users’ guides to the medical literature. IX. How to use an article about health-related quality of life. The Evidence-Based Medicine Working Group. JAMA 1997; 277: 1232–7PubMedCrossRefGoogle Scholar
  3. 3.
    Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76–83PubMedCrossRefGoogle Scholar
  4. 4.
    Juniper EF, Johnston PR, Borkhoff CM, et al. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 151: 66–70PubMedGoogle Scholar
  5. 5.
    Rutten–van Mölken MP, Custers F, Van Doorslaer EK, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8: 888–98PubMedGoogle Scholar
  6. 6.
    Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675–81PubMedCrossRefGoogle Scholar
  7. 7.
    Leidy NK, Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res 1998; 7: 127–34PubMedCrossRefGoogle Scholar
  8. 8.
    Juniper EF, Svensson K, O’Byrne PM, et al. Asthma quality of life during one year of treatment with budesonide with or without formoterol. Eur Respir J 1999; 14: 1038–43PubMedCrossRefGoogle Scholar
  9. 9.
    Juniper EF, Buist AS. Health-related quality of life in moderate asthma: 400μg hydrofluoroalkane beclomethasone dipropionate vs 800μg chlorofluorocarbon beclomethasone dipropionate. The study group. Chest 1999; 116: 1297–303PubMedCrossRefGoogle Scholar
  10. 10.
    Juniper EF, Guyatt GH, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–8PubMedGoogle Scholar
  11. 11.
    Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992; 45: 461–72PubMedCrossRefGoogle Scholar
  12. 12.
    Hyland ME, Finnis S, Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Psychosom Res 1991; 35: 99–110PubMedCrossRefGoogle Scholar
  13. 13.
    Quirk FH, Baveystock CM, Wilson R, et al. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. Eur Respir J 1991; 4: 167–71PubMedGoogle Scholar
  14. 14.
    Maille AR, Kaptein AA, Koning CJ, et al. Developing a quality- of-life questionnaire for patients with respiratory illness. Monaldi Arch Chest Dis 1994; 49: 76–8PubMedGoogle Scholar
  15. 15.
    Creer TL, Wigal JK, Kotses H, et al. A life activities questionnaire for adult asthma. J Asthma 1992; 29: 393–915PubMedCrossRefGoogle Scholar
  16. 16.
    Malo JL, Boulet LP, Dewitte JD, et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol 1993; 91: 1121–7PubMedCrossRefGoogle Scholar
  17. 17.
    Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996; 5: 35–46PubMedCrossRefGoogle Scholar
  18. 18.
    Townsend M, Feeny DH, Guyatt GH, et al. Evaluation of the burden of illness for pediatric asthmatic patients and their parents. Ann Allergy 1991; 67: 403–8PubMedGoogle Scholar
  19. 19.
    Creer TL, Wigal JK, Kotses H, et al. A life activities questionnaire for childhood asthma. J Asthma 1993; 30: 467–73PubMedCrossRefGoogle Scholar
  20. 20.
    Christie MJ, French D, Sowden A, et al. Development of childcentered disease-specific questionnaires for living with asthma. Psychosom Med 1993; 55: 541–8PubMedGoogle Scholar
  21. 21.
    Nocon A. Social and emotional impact of childhood asthma. Arch Dis Child 1991; 66: 458–60PubMedCrossRefGoogle Scholar
  22. 22.
    Usherwood TP, Scrimgeour A, Barber JH. Questionnaire to measure perceived symptoms and disability in asthma. Arch Dis Child 1990; 65: 779–81PubMedCrossRefGoogle Scholar
  23. 23.
    Osman L, Silverman M. Measuring quality of life for young children with asthma and their families. Eur Respir J Suppl. 1996; 21: 35s–41PubMedGoogle Scholar
  24. 24.
    Guyatt GH, Juniper EF, Feeny DH, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8PubMedCrossRefGoogle Scholar
  25. 25.
    Rosenbaum PL, Saigal S. Measuring health–related quality of life in pediatric populations: conceptual issues. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippencott-Raven Publishers, 1996: 785–91Google Scholar
  26. 26.
    Wood PR, Hidalgo HA, Prihoda TJ, et al. Comparison ofHispanic children’s and parents’ responses to questions about the child’s asthma. Arch Pediatr Adolesc Med 1994; 148: 43CrossRefGoogle Scholar
  27. 27.
    Theunissen NC, Vogels TG, Koopman HM, et al. The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 1998; 7: 387–97PubMedCrossRefGoogle Scholar
  28. 28.
    Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments: comparison of instruments for measuring asthma-specific quality of life. Eur Respir J 1997; 10: 2285–94PubMedCrossRefGoogle Scholar
  29. 29.
    Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998; 101: 163–70PubMedCrossRefGoogle Scholar
  30. 30.
    Stewart AL, Hays R, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–32PubMedCrossRefGoogle Scholar
  31. 31.
    Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805PubMedCrossRefGoogle Scholar
  32. 32.
    Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994; 149 (2 Pt 1): 371–5PubMedGoogle Scholar
  33. 33.
    Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94 (2 Pt 1): 182–8PubMedCrossRefGoogle Scholar
  34. 34.
    Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995; 113: 104–9PubMedCrossRefGoogle Scholar
  35. 35.
    Juniper EF, Norman GR, Cox FM, et al. Comparison of the standard gamble rating scale AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001; 18: 1–7CrossRefGoogle Scholar
  36. 36.
    Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1–30PubMedCrossRefGoogle Scholar
  37. 37.
    Kaplan RM, Anderson JP, Wu AW, et al. The Quality of Wellbeing Scale: application in AIDS, cystic fibrosis and arthritis. Med Care 1989; 27: S27–43PubMedCrossRefGoogle Scholar
  38. 38.
    Feeny D, Furlong W, Barr RD, et al. Acomprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992; 10: 923–8PubMedGoogle Scholar
  39. 39.
    EuroQol — a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199–208Google Scholar
  40. 40.
    Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115: 1265–70PubMedCrossRefGoogle Scholar
  41. 41.
    Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of theMini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14: 32–8PubMedCrossRefGoogle Scholar
  42. 42.
    Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81–7PubMedCrossRefGoogle Scholar
  43. 43.
    Guyatt GH, Juniper EF, Walter SD, et al. Interpreting treatment effects in randomised trials. BMJ 1998; 101: 163–70Google Scholar
  44. 44.
    Grossman PR, Stanford RH, Edwards L, et al. The impact of fluticasone propionate compared to zafirlukast on asthma related quality of life. Am J Respir Crit Care Med 2000; 161 (3): 788Google Scholar
  45. 45.
    Reese PR, Mather DB, Mahajan P, et al. Combination of salmeterol/fluticasone propionate via Diskus improves quality of life in asthma patients. J Allergy Clin Immunol 103 (1 Pt 2): S69Google Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  • Elizabeth F. Juniper
    • 1
  1. 1.Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada

Personalised recommendations